News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Less Than Two Weeks Remain before Deadline in Class-Action Lawsuit Against Dendreon Corporation, Says Hagens Berman
September 22, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP reminds investors that those who wish to serve as lead plaintiff in a class-action lawsuit against Dendreon (NASDAQ:DNDN) have less than two weeks from today to file their motion.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
Government
Rare Pediatric Disease Vouchers, PBM Reform, up for Vote in House
January 21, 2026
·
2 min read
·
Tristan Manalac
Legal
Former Emergent CEO Hit With Insider Trading Lawsuit
January 16, 2026
·
2 min read
·
Tristan Manalac
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
January 15, 2026
·
2 min read
·
Annalee Armstrong